46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details
臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05718583 (ClinicalTrials.gov) | February 1, 2023 | 30/1/2023 | Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders | A Pilot Proof of Concept Study of the Effects of Administration of a Short Chain Fatty Acid (SCFA) Supplement in Rheumatoid Arthritis Inadequate Responders (EASi-RAIR) | Rheumatoid Arthritis | Dietary Supplement: Butyrate | NYU Langone Health | Arthritis Foundation | Recruiting | 18 Years | N/A | All | 35 | N/A | United States |
| 2 | NCT05576597 (ClinicalTrials.gov) | August 23, 2022 | 7/10/2022 | Effect of Butyrate Supplement on Rheumatoid Arthritis | A Pilot Study to Evaluate Efficacy and Safety of Butyrate Supplement in the Treatment of Rheumatoid Arthritis | Rheumatoid Arthritis | Drug: Sodium Butyrate | Peking University People's Hospital | NULL | Recruiting | 18 Years | N/A | All | 30 | Phase 2 | China |